Trade Summary

5 days ago, RA CAPITAL MANAGEMENT, L.P., serving as Dir at Artiva Biotherapeutics, Inc. (ARTV), purchased 160,354 shares at $8.93 per share, for a total transaction value of $1,432,118.86. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 16,977,927 shares of ARTV.

This purchase represents a 0.95% increase in RA CAPITAL MANAGEMENT, L.P.'s stake in the company.

The trade was executed on Thursday, July 16, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 20, 2026 at 6:08 PM ET, 4 days after the trade was made.

Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.